MEDIUM confidence: 100% data completeness, but the composite (60) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-08-02.
Avg target $253 (last qtr, 14 analysts) → $257 (last mo, 13) (+1.6%).
Buy-rated share 78% → 77% over ~3 months (-1pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $3.09 | $3.07 | -0.6% |
| Apr 2026 | $2.85 | $2.90 | +1.8% |
| Jan 2026 | $2.53 | $2.87 | +13.4% |
| Oct 2025 | $1.76 | $1.93 | +9.7% |
| Aug 2025 | $2.43 | $2.49 | +2.5% |
| Apr 2025 | $2.48 | $2.66 | +7.3% |
| Jan 2025 | $1.37 | $2.80 | +104.4% |
| Oct 2024 | $0.69 | $0.95 | +37.7% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$636K over 180 days (0 open-market buys, 4 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $3.8B— | $4.1B+8.7% | $4.4B+6.8% | $5.4B+21.9% | $5.8B+7.9% |
| EPS (dil.) | $2.58— | $2.28-11.6% | $3.40+49.1% | $8.32+144.7% | $10.87+30.6% |
| Free Cash Flow | $102M— | $71M-29.9% | $223M+212.3% | $414M+85.5% | —— |
| Gross Margin | 13.1% | 12.1%-1.0pp | 14.2%+2.1pp | 18.2%+4.0pp | 18.6%+0.4pp |
| Operating Margin | 4.2% | 3.5%-0.7pp | 5.2%+1.7pp | 9.5%+4.3pp | 10.7%+1.2pp |
| Net Margin | 3.1% | 2.5%-0.6pp | 3.5%+1.0pp | 7.1%+3.6pp | 8.4%+1.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 5.4%/yr (revenue basis).
Base free cash flow $236M (avg FY2023–FY2025; latest year $414M) · equity value $10.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 60 indicates a moderately attractive stock, driven by strong momentum and high profitability, with an ROE near 124%. The stock's value score is lower due to a P/E of 22.0 and EV/EBITDA of 14.5, indicating it trades at a premium. Notably, the short-term score of 65 diverges from the long-term score of 54, suggesting recent performance, including a 94.7% return over the past three months, is outpacing its long-term prospects.